Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06939413 · ClinicalTrials.gov registry record · NA
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
A NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by Diabetes Solutions International.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06939413: Recruiting NA study of Type 2 Diabetes Mellitus (T2DM), sponsored by Diabetes Solutions International.
NCT06939413 is a NA study of Type 2 Diabetes Mellitus (T2DM) that is actively recruiting participants, run by Diabetes Solutions International. The registered enrollment target is 40 participants, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06939413, a NA study of Type 2 Diabetes Mellitus (T2DM), is actively recruiting participants, sponsored by Diabetes Solutions International.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. The CGM and RPM are used as an adjunct to usual care. The main questions it aims to answer are: Does use of CGM \& RPM improve A1c? Does use of CGM \& RPM improve the percent of time spent with glucose levels between 70-180 mg/dl? Does the diabetes care management program improve diabetes related distress? Participants enrolled in the study will be wearing a CGM. Participants will be able to see the glucose readings from the CGM and see how their glucose level responds to food, physical activity, medications and daily life. The diabetes primary care team will be remotely monitoring the participant's glucose data from the CGM. They will reach out to the participant to make adjustments in treatment regimen as needed. Participants will answer a "Problem Areas in Diabetes"questionnaire that asks questions about diabetes related distress.
Primary Outcome
A1c is a blood test that measures the average glucose level over the previous 2 to 3 months. A normal A1c is 5.7 to 6.4%. The usual goal for most people with diabetes is \< 7% or as close to normal as possible without low glucose levels
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor (CGM)
Study Locations (1)
Massachusetts
- Community Health Center of Franklin County - Greenfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06939413 shows while recruiting
NCT06939413 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 520-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor (CGM) is the first listed.
NCT06939413 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06939413 about?
NCT06939413 is a clinical study titled "Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations". The goal of this 52 week prospective study is to learn whether a Diabetes Care Management Program using a continuous glucose monitor (CGM) and remotely monitoring (RPM) glucose readings can help improve glucose levels and diabetes related distress in individuals with uncontrolled type 2 diabetes. Th...
What is the current status of trial NCT06939413?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-18. Estimated completion is 2026-10.
What conditions does trial NCT06939413 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM).
What interventions are being tested in trial NCT06939413?
The interventions under investigation include: Continuous glucose monitor (CGM) (DEVICE).
Who is sponsoring clinical trial NCT06939413?
This trial is sponsored by Diabetes Solutions International, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06939413 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus (T2DM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06939413's enrollment target sits among peer trials
40 20th of 24 higher than 3 of 24 other Type 2 Diabetes Mellitus (T2DM) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus (T2DM) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Achieving Routine Intervention and Screening for Emotional Health
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI